Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Research roundup: Insurance coverage in the Great Recession; PCIP vs. CHIP

The researchers how physicians examined claims of lower back back pain and note that part of the "rising economic cost of this epidemic is the burgeoning use of indiscriminate imaging," specifically MRIs. Researchers divided patients into two groups and "the treating physician in group 1 patients was blinded to the MRI results, while the physician for group 2 patients decided on treatment after reviewing the MRI findings."

17 Dec 2011

Berlin Heart receives FDA approval for EXCOR Pediatric System

The U.S. Food and Drug Administration today approved a medical device that supports the weakened heart of children with heart failure to help keep them alive until a donor for a heart transplant can be found.

17 Dec 2011

MHI cardiologists perform first clinical procedure in Canada using MitraClip system

The interventional cardiology team at the Montreal Heart Institute (MHI) recently conducted the first clinical procedure in Canada using the MitraClip system, which is designed to treat patients suffering from mitral valve failure, a very common heart defect that affects an estimated 1 out 5 people to various extents starting at the age of 55.

16 Dec 2011

Health literacy linked with proper daily care and management for heart failure patients

A patient's education level is not a fail-safe predictor of how well they will manage symptoms related to complicated chronic diseases, such as heart failure, according to a Purdue University study.

16 Dec 2011

Patients need less blood after surgery than is widely thought

Patients need less blood after surgery than is widely thought. A new study comparing two plans for giving blood transfusions following surgery showed no ill effects from postponing transfusion until patients develop signs of anemia or their hemoglobin concentration falls below 8 g/dL.

16 Dec 2011

TJC approves UCSD's DSC Certification for Ventricular Assist Device

The Joint Commission (TJC) has approved UC San Diego Health System's Disease-Specific Care (DSC) Certification for Ventricular Assist Device.

16 Dec 2011

Critical Diagnostics receives FDA clearance for Presage ST2 Assay

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, announced today that the U.S. Food and Drug Administration has cleared the company's Presage ST2 Assay for use as an aid in assessing the prognosis of patients diagnosed with chronic heart failure.

16 Dec 2011

First Total Artificial Heart implant performed at NewYork-Presbyterian/Columbia

Surgeons at NewYork-Presbyterian Hospital/Columbia University Medical Center performed the first Total Artificial Heart implant in the New York City area to replace a patient's dying heart.

15 Dec 2011

Roundup: Iowans question Wellmark premium hikes; Fla. Medicare audit; Mich. nursing home scandals

The Wellmark Blue Cross/Blue Shield vice president faced dozens of angry customers and tried to explain why the health insurer wants to increase their premiums by 9.4 percent. ... Barbed questions flew throughout the hearing before the state insurance commissioner, who will decide whether to grant Wellmark's proposed increase for 86,000 Iowans who buy their own insurance policies.

13 Dec 2011

Onyx announces data from three carfilzomib studies on RRMM

Onyx Pharmaceuticals, Inc. today announced summaries of three poster presentations of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.

12 Dec 2011

FDA committee votes against CardioMEMS' Champion Heart Failure Monitoring System

CardioMEMS announced today that the U.S. Food and Drug Administration's (FDA) Circulatory Systems Devices advisory panel voted against the Champion Heart Failure Monitoring System, the first wireless, permanently implantable device that allows cardiologists to monitor heart failure patients from their homes.

9 Dec 2011

Positive results from Genentech's pertuzumab plus Herceptin Phase III study on HER2-positive mBC

Genentech, a member of the Roche Group, today announced results from CLEOPATRA, the first randomized Phase III study of the investigational HER2-targeted medicine pertuzumab.

8 Dec 2011

Stem cells for the damaged heart

Stem cell research got its latest boost. For the first time, stem cells were injected into the hearts of humans who had suffered serious heart damage, and patients improved dramatically. The scientists found that the stem cells grew into new heart cells to replace the damaged tissue.

5 Dec 2011

Factors associated with increased risk of in-hospital falls after total hip or knee replacement surgery

Investigators from Hospital for Special Surgery have identified factors that are associated with an increased risk of in-hospital falls after total hip or knee replacement surgery.

5 Dec 2011

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis Pharmaceuticals Corporation will showcase more than one hundred and sixty presentations on data from its robust oncology portfolio at two key medical congresses this month, demonstrating significant advances for patients with cancers and hematological diseases.

3 Dec 2011

Research roundup: Recession's big impact on men's insurance coverage

Researchers examined three sets of surveillance data and found that of the estimated 1.2 million persons in the United States living with the human immunodeficiency virus, 942,000 persons were aware of their infection. More than three-quarters of those were "linked to care" and among HIV-infected adults in care, "45 percent received prevention counseling, and 89 percent were prescribed antiretroviral therapy."

3 Dec 2011

Longer looks: Life of a Medicare demo project; Broken hearts; AIDS funding

Today's Medicare demonstration project might determine how physicians interact with the program tomorrow, so naturally such projects generate a lot of buzz in the health care community. Lately, some of that buzz has been about how demos might provide part of the solution for Medicare's payment problems.

2 Dec 2011

NYU Langone establishes new LVAD Program for patients with advanced heart failure

The Cardiac & Vascular Institute at NYU Langone Medical Center has established its new LVAD Program. This surgical intervention program offers eligible, advanced heart failure patients implantation of the latest, lifesaving tool - a left ventricular assist device.

2 Dec 2011

New discovery of adult stem cells gives fresh possibilities for heart regeneration

Sydney researchers have discovered a new population of adult stem cells in the heart, which could augment the development of new regeneration and repair therapies for people who have suffered heart attack or heart failure, the leading cause of death in Australia.

1 Dec 2011

Boston Scientific provides new warranty for ICDs and CRT-Ds

Boston Scientific Corporation announced that, along with today's introduction of a new family of INCEPTA and ENERGEN implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), it is providing an extended warranty for these devices in the U.S. and many international countries of up to 10 years, depending on model.

1 Dec 2011

Heart Failure News and Research

Further Reading

Research roundup: Insurance coverage in the Great Recession; PCIP vs. CHIP

Berlin Heart receives FDA approval for EXCOR Pediatric System

MHI cardiologists perform first clinical procedure in Canada using MitraClip system

Health literacy linked with proper daily care and management for heart failure patients

Patients need less blood after surgery than is widely thought

TJC approves UCSD's DSC Certification for Ventricular Assist Device

Critical Diagnostics receives FDA clearance for Presage ST2 Assay

First Total Artificial Heart implant performed at NewYork-Presbyterian/Columbia

Roundup: Iowans question Wellmark premium hikes; Fla. Medicare audit; Mich. nursing home scandals

Onyx announces data from three carfilzomib studies on RRMM

FDA committee votes against CardioMEMS' Champion Heart Failure Monitoring System

Positive results from Genentech's pertuzumab plus Herceptin Phase III study on HER2-positive mBC

Stem cells for the damaged heart

Factors associated with increased risk of in-hospital falls after total hip or knee replacement surgery

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Research roundup: Recession's big impact on men's insurance coverage

Longer looks: Life of a Medicare demo project; Broken hearts; AIDS funding

NYU Langone establishes new LVAD Program for patients with advanced heart failure

New discovery of adult stem cells gives fresh possibilities for heart regeneration

Boston Scientific provides new warranty for ICDs and CRT-Ds

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News